Intrinsic Value of S&P & Nasdaq Contact Us

Nasus Pharma Ltd. NSRX NYSE

NYSE • Healthcare • Biotechnology • IL • USD

SharesGrow Score
46/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$22.00
+895.5%

Nasus Pharma Ltd. (NSRX) has 10 identified peers for comparison in the Healthcare sector. Peers include ACET, ACRV, ADAG, CRVO, FBIO, GANX and others.

NSRX has a market capitalization of $19.03M, compared to an average peer market cap of $70.83M. NSRX is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message